PTEN, the negative regulator of PI3K signalling, decreases its expression in many cancers, and may be downregulated through several mechanisms, including mutation, loss of heterozygosity, methylation, aberrant expression of regulatory microRNA, and protein instability [124,125]. This evidence concerns the gene PTEN and cancer.